Alumni raised $1.45B in 2022 - Download Free Report Now

Asmacure

Nicotinic receptor agonist compounds for the treatment of asthma and other inflammatory respiratory and non-respiratory diseases.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Asmacure plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About Asmacure

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Companies We Work With